January 18, 2012

Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine

- Supply of injectable inactivated polio vaccine, a major step in the world’s fifth most populous country made possible by partnership between Sanofi Pasteur and Bio-Manguinhos, the Institute of Technology in Immuno-biologicals of Fiocruz -

 

Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine
- Supply of injectable inactivated polio vaccine, a major step in the world’s fifth most populous country made possible by partnership between Sanofi Pasteur and Bio-Manguinhos, the Institute of Technology in Immuno-biologicals of Fiocruz -

Lyon, France – January 18, 2012 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that Brazil has chosen to introduce injectable polio vaccine in its national immunization program with inactivated polio vaccine (IPV) from Sanofi Pasteur. The IPV doses will be provided by Bio-Manguinhos, the Institute of Technology in Immuno-biologicals of the Oswaldo Cruz Foundation (Fiocruz), through an agreement with Sanofi Pasteur. IPV will be included in the Brazilian national immunization program starting in 2012.